Hottub News

Everest Medicines Announces the Acceptance and Priority Review of VELSIPITY(R) Manufacturing Localization Application by the Center for Drug Evaluation of China's NMPA, Driving Continued Commercial Momentum

3 reports from 2 outlets in 1 language · first reported · updated · JSON

Economy & businessNational Music Publishers' Association

Reports

  1. Everest Medicines Announces the Acceptance and Priority Review of VELSIPITY(R) Manufacturing Localization Application by the Center for Drug Evaluation of China's NMPA, Driving Continued Commercial MomentumPublished by prwire.com.au, jcnnewswire.com, jcnnewswire.com ·

More in Economy & business

  1. A gut punch in Ohio: Nearly 1,400 laid off at truck factory just days before Trump rally83 outlets
  2. OPEC+ agrees in principle to keep oil output targets unchanged in November, delegate says62 outlets
  3. G7 releases 100 million barrels of oil and fuel - what this means for German diesel prices94 outlets
  4. Release of millions of barrels of crude oil and diesel by the G7: what effects to expect on fuel prices?92 outlets
  5. A $28B hemp THC industry is fighting to save itself from a looming federal ban72 outlets
  6. Experts call for open trade, investment policies to cushion global shocks44 outlets